Literature DB >> 21711332

Ultraviolet B radiation and reactive oxygen species modulate interleukin-31 expression in T lymphocytes, monocytes and dendritic cells.

C Cornelissen1, R Brans, K Czaja, C Skazik, Y Marquardt, G Zwadlo-Klarwasser, A Kim, D R Bickers, J Lüscher-Firzlaff, B Lüscher, J M Baron.   

Abstract

BACKGROUND: Interleukin (IL)-31 is a novel Th2 T-cell cytokine that induces pruritus and dermatitis in transgenic mice. While enhanced mRNA expression of this cytokine is detected in skin samples of inflammatory skin diseases, the regulation of IL-31 expression is poorly understood.
OBJECTIVES: To assess the effects of ultraviolet (UV) B radiation and H₂O₂ on IL-31 mRNA and protein expression in skin and different peripheral blood mononuclear cells (PBMCs).
METHODS: The effects of UVB radiation and H₂O₂, as a prototypic reactive oxygen species, on IL-31 mRNA and protein expression were analysed in various inflammation-related cells and murine skin tissue. RESULTSTreatment of cells with UVB radiation and H₂ O₂ strongly induced IL-31 mRNA and protein expression in human PBMCs and in the skin of SKH-1 mice. Following exposure to UVB or H₂O₂, we observed increased expression of IL-31 mRNA in T cells, monocytes, macrophages, and immature and especially mature dendritic cells. H₂O₂ treatment but not UVB radiation led to a moderate upregulation of IL-31 mRNA expression in epidermal keratinocytes and dermal fibroblasts. Pretreatment of T lymphocytes with the MAPK p38 inhibitor SB203580 or the MEK1 inhibitor U0126 reduced the stimulatory effect of H₂O₂. These experiments suggest that p38 is involved in the regulation of IL-31 expression in human skin.
CONCLUSIONS: Our studies reveal that UVB and reactive oxygen species stimulate the expression of IL-31 in PBMCs and skin, especially in T cells, monocytes and monocyte-derived dendritic cells.
© 2011 The Authors. BJD © 2011 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21711332     DOI: 10.1111/j.1365-2133.2011.10487.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  19 in total

1.  IL-31 Induces Chemotaxis, Calcium Mobilization, Release of Reactive Oxygen Species, and CCL26 in Eosinophils, Which Are Capable to Release IL-31.

Authors:  Nikola Kunsleben; Urda Rüdrich; Manuela Gehring; Natalija Novak; Alexander Kapp; Ulrike Raap
Journal:  J Invest Dermatol       Date:  2015-03-19       Impact factor: 8.551

2.  Itch in dermatomyositis: the role of increased skin interleukin-31.

Authors:  H J Kim; M Zeidi; D Bonciani; S M Pena; J Tiao; S Sahu; V P Werth
Journal:  Br J Dermatol       Date:  2018-06-21       Impact factor: 9.302

Review 3.  IL-31: State of the Art for an Inflammation-Oriented Interleukin.

Authors:  Francesco Borgia; Paolo Custurone; Federica Li Pomi; Raffaele Cordiano; Clara Alessandrello; Sebastiano Gangemi
Journal:  Int J Mol Sci       Date:  2022-06-10       Impact factor: 6.208

4.  Correlation of IL-31 gene polymorphisms with susceptibility and clinical recurrence of bladder cancer.

Authors:  Qin Li; Tielong Tang; Peng Zhang; Chenlu Liu; Yan Pu; Yan Zhang; Huizi Song; Yanyun Wang; Yaping Song; Min Su; Bin Zhou; Lin Zhang
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

Review 5.  Interleukin-31: a novel diagnostic marker of allergic diseases.

Authors:  Anja Rabenhorst; Karin Hartmann
Journal:  Curr Allergy Asthma Rep       Date:  2014-04       Impact factor: 4.806

6.  The interleukin (IL)-31/IL-31R axis contributes to tumor growth in human follicular lymphoma.

Authors:  E Ferretti; C Tripodo; G Pagnan; C Guarnotta; D Marimpietri; M V Corrias; D Ribatti; S Zupo; G Fraternali-Orcioni; J L Ravetti; V Pistoia; A Corcione
Journal:  Leukemia       Date:  2014-10-06       Impact factor: 11.528

7.  Interleukin-31, a Potent Pruritus-Inducing Cytokine and Its Role in Inflammatory Disease and in the Tumor Microenvironment.

Authors:  Alain H Rook; Kathryn A Rook; Daniel J Lewis
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Production of IL-31 in CD45RO+CLA+H4R+ T Cells in Atopic Dermatitis.

Authors:  Chul Hwan Bang; Ji Young Song; Yu Mee Song; Ji Hyun Lee; Young Min Park; Jun Young Lee
Journal:  J Clin Med       Date:  2021-05-04       Impact factor: 4.241

9.  Macrophage migration inhibitory factor protects from nonmelanoma epidermal tumors by regulating the number of antigen-presenting cells in skin.

Authors:  Tania Brocks; Oleg Fedorchenko; Nicola Schliermann; Astrid Stein; Ute M Moll; Seth Seegobin; Manfred Dewor; Michael Hallek; Yvonne Marquardt; Katharina Fietkau; Ruth Heise; Sebastian Huth; Herbert Pfister; Juergen Bernhagen; Richard Bucala; Jens M Baron; Guenter Fingerle-Rowson
Journal:  FASEB J       Date:  2016-10-19       Impact factor: 5.834

10.  Increased levels of interleukin 31 (IL-31) in osteoporosis.

Authors:  Lia Ginaldi; Massimo De Martinis; Fedra Ciccarelli; Salvatore Saitta; Selene Imbesi; Carmen Mannucci; Sebastiano Gangemi
Journal:  BMC Immunol       Date:  2015-10-08       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.